These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27372040)

  • 21. Angiographic and Midterm Outcomes of Bioresorbable Vascular Scaffold for Coronary Bifurcation Lesions.
    Paradies V; Vlachojannis GJ; Royaards KJ; Wassing J; van der Ent M; Smits PC
    Am J Cardiol; 2018 Dec; 122(12):2035-2042. PubMed ID: 30360886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new novolimus-eluting bioresorbable scaffold for large coronary arteries: an OCT study of acute mechanical performance.
    Boeder NF; Koepp T; Dörr O; Bauer T; Mattesini A; Elsässer A; Möllmann H; Blachutzik F; Achenbach S; Ghanem A; Hamm CW; Nef HM
    Int J Cardiol; 2016 Oct; 220():706-10. PubMed ID: 27393853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study.
    Gomez-Lara J; Diletti R; Brugaletta S; Onuma Y; Farooq V; Thuesen L; McClean D; Koolen J; Ormiston JA; Windecker S; Whitbourn R; Dudek D; Dorange C; Veldhof S; Rapoza R; Regar E; Garcia-Garcia HM; Serruys PW
    EuroIntervention; 2012 Jun; 8(2):214-24. PubMed ID: 22030265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is high pressure postdilation safe in bioresorbable vascular scaffolds? Optical coherence tomography observations after noncompliant balloons inflated at more than 24 atmospheres.
    Fabris E; Caiazzo G; Kilic ID; Serdoz R; Secco GG; Sinagra G; Lee R; Foin N; Di Mario C
    Catheter Cardiovasc Interv; 2016 Apr; 87(5):839-46. PubMed ID: 26370357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optical Coherence Tomography and Stent Boost Imaging Guided Bioresorbable Vascular Scaffold Overlapping for Coronary Chronic Total Occlusion Lesion.
    Li H; Rha SW; Choi CU; Oh DJ
    Yonsei Med J; 2017 Sep; 58(5):1071-1074. PubMed ID: 28792157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Follow-up evaluation of unapposed bioresorbable vascular scaffold at a coronary bifurcation using optical coherence tomography.
    Danson E; Bhindi R; Hansen P
    Int J Cardiol; 2014 Dec; 177(2):e84-6. PubMed ID: 25456696
    [No Abstract]   [Full Text] [Related]  

  • 27. Major coronary evaginations following implantation of bioresorbable vascular scaffolds - Clinical and OCT characteristics.
    Blachutzik F; Achenbach S; Marwan M; Röther J; Tröbs M; Schneider R; Nef H; Weissner M; Schlundt C
    Cardiovasc Revasc Med; 2019 Jun; 20(6):485-491. PubMed ID: 30097188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Assessment of effectiveness and security in high pressure postdilatation of bioresorbable vascular scaffolds during percutaneous coronary intervention. Study in a contemporary, non-selected cohort of Spanish patients".
    Abellas-Sequeiros RA; Ocaranza-Sanchez R; Galvão Braga C; Raposeiras-Roubin S; Lopez-Otero D; Cid-Alvarez B; Souto-Castro P; Trillo-Nouche R; Gonzalez-Juanatey JR
    Int J Cardiol; 2016 Sep; 219():264-70. PubMed ID: 27343418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neoatherosclerosis 5 Years After Bioresorbable Vascular Scaffold Implantation.
    Moriyama N; Shishido K; Tanaka Y; Yokota S; Hayashi T; Miyashita H; Koike T; Yokoyama H; Takada T; Nishimoto T; Ochiai T; Tobita K; Yamanaka F; Mizuno S; Murakami M; Takahashi S; Saito S
    J Am Coll Cardiol; 2018 May; 71(17):1882-1893. PubMed ID: 29699614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance.
    Mattesini A; Secco GG; Dall'Ara G; Ghione M; Rama-Merchan JC; Lupi A; Viceconte N; Lindsay AC; De Silva R; Foin N; Naganuma T; Valente S; Colombo A; Di Mario C
    JACC Cardiovasc Interv; 2014 Jul; 7(7):741-50. PubMed ID: 25060016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioresorbable vascular scaffolds for small vessels coronary disease: The BVS-save registry.
    Latini RA; Granata F; Ielasi A; Varricchio A; Moscarella E; Tespili M; Cortese B
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):380-7. PubMed ID: 27038332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term follow-up after bioresorbable vascular scaffold implantation in STEMI patients: PRAGUE-19 study update.
    Toušek P; Kočka V; Malý M; Kozel M; Petr R; Hajsl M; Jarkovský J; Lisa L; Buděšínský T; Widimský P
    EuroIntervention; 2016 May; 12(1):23-9. PubMed ID: 27173858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronary artery bifurcation with chronic total occlusion: A "biodegradable" strategy for a challenging treatment with optical coherence tomography analysis.
    Inga G; Buccheri D; Piraino D; Carella M; Andolina G
    Int J Cardiol; 2016 Sep; 218():23-24. PubMed ID: 27232906
    [No Abstract]   [Full Text] [Related]  

  • 34. Late neoatherosclerotic scaffold failure: An unexpected achilles heel for current bioresorbable scaffold technology?
    Hiltrop N; Jorge C; Bennett J; Adriaenssens T
    Int J Cardiol; 2016 Nov; 223():133-135. PubMed ID: 27537739
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of early clinical outcomes between ABSORB bioresorbable vascular scaffold and everolimus-eluting stent implantation in a real-world population.
    Costopoulos C; Latib A; Naganuma T; Miyazaki T; Sato K; Figini F; Sticchi A; Carlino M; Chieffo A; Montorfano M; Colombo A
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):E10-5. PubMed ID: 24909303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study.
    Vaquerizo B; Barros A; Pujadas S; Bajo E; Estrada D; Miranda-Guardiola F; Rigla J; Jiménez M; Cinca J; Serra A
    EuroIntervention; 2015 Sep; 11(5):555-63. PubMed ID: 25499833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term intravascular follow-up of coronary bifurcation treatment with Absorb bioresorbable vascular scaffold.
    Vanhaverbeke M; McCutcheon K; Dubois C; Bennett J
    Acta Cardiol; 2018 Aug; 73(4):413-414. PubMed ID: 29277145
    [No Abstract]   [Full Text] [Related]  

  • 38. Is bioresorbable vascular scaffold acute recoil affected by baseline renal function and scaffold selection?
    Gunes HM; Yılmaz FK; Gokdeniz T; Demir GG; Guler E; Guler GB; Karaca O; Cakal B; İbişoğlu E; Boztosun B
    Int J Cardiol; 2016 Dec; 224():388-393. PubMed ID: 27681252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry.
    Naganuma T; Colombo A; Lesiak M; Capodanno D; Gori T; Nef H; Caramanno G; Naber C; Di Mario C; Ruparelia N; Capranzano P; Wiebe J; Araszkiewicz A; Geraci S; Kawamoto H; Pyxaras S; Mattesini A; Münzel T; Tamburino C; Latib A
    Catheter Cardiovasc Interv; 2017 Jan; 89(1):47-56. PubMed ID: 27414021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
    Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
    JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.